A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
Celgene
Celgene
Asan Medical Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Ontario Clinical Oncology Group (OCOG)
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital